New research finds smoking significantly increases the risk of a person developing schizophrenia or depression.
Non-invasive brain stimulation may improve smoking abstinence rates for 3 to 6 months after quitting.
Study reports a significant decline in smoking for those with major depression and substance use disorders, signifying smoking cessation treatments and campaigns are effective in targeting those in groups considered high risk for developing nicotine addiction.
A single time vaping increases oxidative stress levels up to four times in non-smokers.
Non-invasive brain stimulation, such as rTMS, helps to reduce smoking frequency in nicotine-dependent people, a new study reports. Stimulating the dorsolateral prefrontal cortex with repetitive transcranial magnetic stimulation significantly reduced smoking frequency.
A new study reveals a number of different factors, including smoking, age, education levels, sex, handedness, and family medical history, which can have an impact on reaction time.
A new large-scale study links smoking and cardiovascular disease to an increased risk of developing dementia. Smoking and cardiovascular disease impact memory and learning throughout adulthood, starting at age 18. Researchers say smoking has the biggest impact on cognitive function in women, while cardiovascular disease has a more detrimental impact on cognition in men.
Stress, boredom, and more free time may account for the rise in cigarette consumption in smokers during the COVID pandemic.
Between 60-90% of people with schizophrenia smoke, compared to between 15-24% of the general population. A new study found 40% of those with schizophrenia stopped smoking traditional cigarettes after 12 weeks of switching to e-cigarettes. Researchers also reported a significant number of participants sustained their reduction in smoking or completely stopped smoking at the end of the 12-week study.